Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient.

Knechtl, G V; Seyed Jafari, S M; Berger, T; Rammlmair, A; Feldmeyer, L; Borradori, L (2022). Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patient. Journal of the European Academy of Dermatology and Venereology : JEADV, 36(4), e251-e253. Wiley 10.1111/jdv.17868

[img] Text
Acad_Dermatol_Venereol_-_2021_-_Knechtl_-_Development_of_pemphigus_vulgaris_following_mRNA_SARS_CoV_19_BNT162b2_vaccination.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (487kB)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Jafari, Morteza, Berger, Tobias, Rammlmair, Anna, Feldmeyer, Laurence, Borradori, Luca

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1468-3083

Publisher:

Wiley

Language:

English

Submitter:

Andrea Studer-Gauch

Date Deposited:

01 Feb 2022 11:24

Last Modified:

02 Mar 2023 23:35

Publisher DOI:

10.1111/jdv.17868

PubMed ID:

34897817

BORIS DOI:

10.48350/164305

URI:

https://boris.unibe.ch/id/eprint/164305

Actions (login required)

Edit item Edit item
Provide Feedback